-
公开(公告)号:EP4154976A1
公开(公告)日:2023-03-29
申请号:EP21808492.9
申请日:2021-05-13
发明人: MATSUMOTO, Takahiro , MURAKAMI, Masato , NAKANO, Tatsuya , NISHIKAWA, Ryo , KIMURA, Kento , SAMESHIMA, Kou
IPC分类号: B01J35/02 , C07C29/48 , C07C29/50 , C07C31/04 , C07B61/00 , H01M4/86 , H01M4/90 , H01M8/00 , H01M8/02 , H01M8/04 , H01M8/0637 , B01J31/22 , C25B11/073 , C25B3/23 , C25B3/25
摘要: An object of the present invention is to provide a light-driven fuel cell having excellent power generation characteristics, and the present invention relates to a light-driven fuel cell comprising a cathode, an anode, and a proton-permeable membrane between the anode and the cathode,
wherein the anode comprises a photocatalyst for anaerobic methane oxidation reaction, and when the anode is supplied with methane and water and is irradiated with light, methanol, protons and electrons are generated by anaerobic methane oxidation reaction from the methane and the water supplied to the anode; the protons pass through the proton-permeable membrane and move to the cathode; and the electrons move to the cathode via an external circuit,
and wherein the cathode comprises a photocatalyst for aerobic methane oxidation reaction, and when the cathode is supplied with methane and oxygen and is irradiated with light, methanol and water are generated by aerobic methane oxidation reaction from the methane and the oxygen supplied to the cathode and the protons and the electrons moved from the anode. Fig. 3-
公开(公告)号:EP1625850B1
公开(公告)日:2012-02-29
申请号:EP04732786.1
申请日:2004-05-13
发明人: SHINKAI, Seiji , MIZU, Masami , SAKURAI, Kazuo , KOUMOTO, Kazuya , NUMATA, Munenori , MATSUMOTO, Takahiro
CPC分类号: A61K9/0019 , A61K31/7125 , A61K47/36 , A61K2039/55561 , C08B37/0024
摘要: An immunostimulant of a novel type which is a complex of an immunostimulant oligonucleotide with a carrier having a high safety and a high transfection effect. A complex comprising an immunostimulant oligonucleotide and a polysaccharide having a β-1,3-bond (preferably a β-1,3-glucan such as schizophyllan) is formed and then administered as an immunostimulant. Preferable examples of the immunostimulant oligonucleotide include a nonmethylated CpG motif. As the polysaccharide, it is favorable to use one modified with a nucleic acid-binding and/or cytophilic functional group.
-